Hlyk.Pk
HLYK.PK operates in the healthcare facilities and services industry, focusing on biotechnology, and generates revenue primarily through its healthcare services and equipment offerings.
Business. HLYK.PK operates in the healthcare facilities and services industry, focusing on biotechnology, and generates revenue primarily through its healthcare services and equipment offerings.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
HLYK.PK operates in the healthcare facilities and services industry, focusing on biotechnology, and generates revenue primarily through its healthcare services and equipment offerings.
HLYK.PK exhibits a highly leveraged capital structure, with total liabilities of $7.46 million and total equity of -$5.76 million, resulting in a negative debt-to-equity ratio of -0.15. The company's liquidity position is weak, as evidenced by a current ratio of 0.22, indicating that it has insufficient current assets to cover its current liabilities. The operating cash flow of -$1.71 million and free cash flow of -$3.18 million further underscore the company's cash flow challenges.
Profitability metrics for HLYK.PK are concerning, with a net loss of $3.28 million and an operating loss of $1.79 million. The return on equity of 56.93% is misleading due to the negative equity base, and the return on assets of -1.93% indicates that the company is not generating returns on its asset base. These figures fall significantly below the industry median for profitability and returns, suggesting a poor performance relative to its peers.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases the risk associated with the company's revenue streams, as it is highly dependent on a single source of income.
HLYK.PK's growth trajectory is negative, with a net loss and declining cash flows indicating a lack of growth momentum. The company's financial performance suggests that it is not on a path to sustainable growth, and without significant operational improvements or external financing, it may struggle to maintain its operations.
The risk assessment for HLYK.PK highlights a medium liquidity risk and a low dilution risk. The company's negative net cash position after subtracting total debt is a key flag, indicating that it may need to raise additional capital to meet its obligations. The low dilution risk suggests that the company is not currently planning significant equity issuances, but the need for capital could change this outlook.
Recent events and filings for HLYK.PK have not been disclosed in the available data, so no specific recent developments can be reported. However, the company's financial position suggests that it may be under pressure to secure additional financing or restructure its operations to address its liquidity and profitability issues.
- HLYK.PK has a highly leveraged capital structure with a negative equity position.
- The company is experiencing significant operating and net losses, indicating poor profitability.
- Revenue is concentrated in a single segment, increasing business risk.
- The company's liquidity position is weak, with a current ratio of 0.22.
- HLYK.PK is not on a positive growth trajectory and may require external financing to continue operations.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Return On Assetsnet_income / total_assets
- HLYK.PK Market data — financials · 2026-05-28
Ownership & reference
Leadership
- Michael T DentChairman of the Board, Chief Executive Officer
Insider activity
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): 51.0%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): -23.4%Derived (calculated)
- Operating income (YoY) (2025-12-31 vs 2024-12-31): 54.8%Derived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): -84.1%Derived (calculated)
- Return on equity (FY 2025-12-31): 56.9%Derived (calculated)
- Return on assets (FY 2025-12-31): -192.7%Derived (calculated)
- Current ratio (FY 2025-12-31): 0.22xDerived (calculated)
- Debt-to-equity (FY 2025-12-31): -1.30xDerived (calculated)
- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 39.5%Derived (calculated)
- Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): -51.3%Derived (calculated)
- EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): 46.8%Derived (calculated)
- EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): 46.8%Derived (calculated)
- Net income (YoY) (2025-12-31 vs 2024-12-31): 46.5%Derived (calculated)
- Total assets (annual): USD 1.7MSEC XBRL filing
- Total liabilities (annual): USD 7.46MSEC XBRL filing
- EPS (diluted) (annual): USD-PER-SHARES -1SEC XBRL filing
- Cash & equivalents (annual): USD 37.14KSEC XBRL filing
- Operating income (annual): USD -2.11MSEC XBRL filing
- Net income (annual): USD -3.28MSEC XBRL filing
- Total operating expenses (annual): USD 4.18MSEC XBRL filing
- EPS (basic) (annual): USD-PER-SHARES -1SEC XBRL filing
- Shareholders' equity (annual): USD -5.76MSEC XBRL filing
- Current assets (annual): USD 1.55MSEC XBRL filing
- Current liabilities (annual): USD 7.01MSEC XBRL filing